Cho‐Chin Cheng

643 total citations
8 papers, 148 citations indexed

About

Cho‐Chin Cheng is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Cho‐Chin Cheng has authored 8 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Cho‐Chin Cheng's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (3 papers) and RNA Interference and Gene Delivery (2 papers). Cho‐Chin Cheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (3 papers) and RNA Interference and Gene Delivery (2 papers). Cho‐Chin Cheng collaborates with scholars based in Germany, South Korea and United States. Cho‐Chin Cheng's co-authors include Martin Feuerherd, Thomas Michler, Xin Wei, Ulrike Protzer, Nikolaus Kneidinger, Mircea Gabriel Stoleriu, Olivia M. Merkel, Domizia Baldassi, Diana Porras-Gonzalez and Gerald Burgstaller and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Controlled Release.

In The Last Decade

Cho‐Chin Cheng

8 papers receiving 146 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cho‐Chin Cheng Germany	6	77	73	20	13	11	8	148
Feiyang Luo China	8	67 0.9×	89 1.2×	18 0.9×	13 1.0×	16 1.5×	20	178
Abdulmonem A. Alsaleh Saudi Arabia	10	75 1.0×	45 0.6×	13 0.7×	13 1.0×	21 1.9×	24	192
Shuyi Song China	8	55 0.7×	77 1.1×	15 0.8×	8 0.6×	15 1.4×	15	149
Kathy Stephens United States	8	110 1.4×	87 1.2×	18 0.9×	10 0.8×	19 1.7×	10	209
Martin Feuerherd Germany	8	90 1.2×	77 1.1×	31 1.6×	18 1.4×	23 2.1×	11	198
Victoria Zaksas United States	5	40 0.5×	50 0.7×	10 0.5×	16 1.2×	11 1.0×	6	109
Heather M. Froggatt United States	5	53 0.7×	70 1.0×	35 1.8×	7 0.5×	17 1.5×	6	147
Wendong Han China	4	79 1.0×	133 1.8×	24 1.2×	19 1.5×	22 2.0×	7	203
Kehu Yuan China	3	49 0.6×	74 1.0×	13 0.7×	8 0.6×	25 2.3×	4	135
Dan‐yun Lai China	6	77 1.0×	116 1.6×	29 1.4×	5 0.4×	5 0.5×	12	170

Countries citing papers authored by Cho‐Chin Cheng

Since Specialization

Citations

This map shows the geographic impact of Cho‐Chin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho‐Chin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho‐Chin Cheng more than expected).

Fields of papers citing papers by Cho‐Chin Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cho‐Chin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho‐Chin Cheng. The network helps show where Cho‐Chin Cheng may publish in the future.

Co-authorship network of co-authors of Cho‐Chin Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Cho‐Chin Cheng. A scholar is included among the top collaborators of Cho‐Chin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cho‐Chin Cheng. Cho‐Chin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Cheng, Cho‐Chin, Catharina Christa, Bernhard Haller, et al.. (2024). SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine. Vaccines. 12(3). 308–308. 3 indexed citations

Beck, Christina M., Deepak Ramanujam, Martin Feuerherd, et al.. (2023). Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage. Nature Communications. 14(1). 4564–4564. 19 indexed citations

Körber, Nina, Cho‐Chin Cheng, Hrvoje Mijočević, et al.. (2023). Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients. Frontiers in Immunology. 14. 1172477–1172477. 5 indexed citations

Baldassi, Domizia, Martin Feuerherd, Cho‐Chin Cheng, et al.. (2022). Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes. Journal of Controlled Release. 345. 661–674. 36 indexed citations

Stadler, Daniela, et al.. (2022). Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing. Computational and Structural Biotechnology Journal. 20. 799–811. 15 indexed citations

Cheng, Cho‐Chin, Catharina Christa, Romina Bester, et al.. (2022). Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients. Vaccines. 10(8). 1328–1328. 11 indexed citations

Svilenov, Hristo L., A. Reiter, Lisa Wolff, et al.. (2021). Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein. Antiviral Research. 196. 105197–105197. 13 indexed citations

Cheng, Cho‐Chin, Martin Feuerherd, Stoyan Velkov, et al.. (2021). Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread. Nucleic Acids Research. 50(1). 333–349. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact